Marine Drugs is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2003. The journal covers Biology (General).
Authors are required to pay an article processing charge to publish in Marine Drugs; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Marine Drugs has published 7,644 articles. Articles are minted with DOIs through the prefix 10.3390.
Keywords
marine natural product
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2003
- DOI prefix
10.3390
ISSN
- electronic
- 1660-3397
Frequently asked questions
Is Marine Drugs peer-reviewed?
Yes — Marine Drugs operates a Anonymous peer review review process.
Does Marine Drugs charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Marine Drugs publish?
Marine Drugs publishes research in Biology (General).
What languages does Marine Drugs accept?
Marine Drugs accepts manuscripts in English.
What is the ISSN of Marine Drugs?
ISSN:
1660-3397 (electronic).How do I submit a manuscript to Marine Drugs?
Submit through the journal's official portal: visit submission page →